{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:12:38Z","timestamp":1761293558304},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,14]],"date-time":"2018-01-14T00:00:00Z","timestamp":1515888000000},"content-version":"vor","delay-in-days":197,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.carpath.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T08:17:52Z","timestamp":1492503472000},"page":"19-22","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G)"],"prefix":"10.1016","volume":"29","author":[{"given":"Sebastiaan H.C.","family":"Klaassen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henny H.","family":"Lemmink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Bijzet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Plattel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten P.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riemer H.J.A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans L.A.","family":"Nienhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouke P.C.","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carpath.2017.04.002_bb0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.carpath.2017.04.002_bb0010","author":"Rowczenio"},{"key":"10.1016\/j.carpath.2017.04.002_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2016.05.020","article-title":"Transthyretin Amyloidosis: A \u201cZebra\u201d of Many Stripes","volume":"68","author":"Semigran","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carpath.2017.04.002_bb0020","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carpath.2017.04.002_bb0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/13506129.2014.967846","article-title":"The \"Wagshurst study\": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy","volume":"21","author":"Bauer","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.carpath.2017.04.002_bb0030","series-title":"Amyloid and related disorders: Surgical Pathology and clinical Correlations","first-page":"229","article-title":"Fat tissue analysis in the management of patients with systemic amyloidosis","author":"Bijzet","year":"2015"},{"issue":"Suppl. 1","key":"10.1016\/j.carpath.2017.04.002_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13506129.2011.574354028","article-title":"Diagnostic performance of transthyretin measurement in fat tissue of patients with ATTR amyloidosis","volume":"18","author":"Hazenberg","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.carpath.2017.04.002_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13506120701260224","article-title":"Diagnostic performance of amyloid A protein quantification in fat tissue of patients with clinical AA amyloidosis","volume":"14","author":"Hazenberg","year":"2007","journal-title":"Amyloid"},{"key":"10.1016\/j.carpath.2017.04.002_bb0045","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Non-Biopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2017.04.002_bb0050","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00259-012-2187-8","article-title":"(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis","volume":"39","author":"Noordzij","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.carpath.2017.04.002_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.carpath.2017.04.002_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.carpath.2017.04.002_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/03009734.2015.1122687","article-title":"99mTc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis","volume":"121","author":"Pilebro","year":"2016","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.carpath.2017.04.002_bb0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.carpath.2017.04.002_bb0075","doi-asserted-by":"crossref","first-page":"e003352","DOI":"10.1161\/CIRCHEARTFAILURE.116.003352","article-title":"Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis","volume":"9","author":"Dungu","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.carpath.2017.04.002_bb0080","first-page":"1027","article-title":"A new transthyretin mutation associated with amyloid cardiomyopathy","volume":"50","author":"Saraiva","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.carpath.2017.04.002_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/humu.1380050302","article-title":"Transthyretin mutations in health and disease","volume":"5","author":"Saraiva","year":"1995","journal-title":"Hum Mutat"},{"key":"10.1016\/j.carpath.2017.04.002_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/13506120009146252","article-title":"Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser","volume":"7","author":"Janunger","year":"2000","journal-title":"Amyloid"},{"key":"10.1016\/j.carpath.2017.04.002_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jns.12153","article-title":"\u201cRed-flag\u201d symptom clusters in transthyretin familial amyloid polyneuropathy","volume":"21","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.carpath.2017.04.002_bb0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.carpath.2017.04.002_bb0105","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood-2014-06-580720","article-title":"Two types of amyloid in a single heart","volume":"124","author":"Mahmood","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.carpath.2017.04.002_bb0110","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carpath.2017.04.002_bb0115","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.carpath.2017.04.002_bb0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/13506129.2015.1063485","article-title":"Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)","volume":"22","author":"Cho","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.carpath.2017.04.002_bb0125","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2017.04.002_bb0130","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105488071630237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105488071630237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T16:26:11Z","timestamp":1549815971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105488071630237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":26,"alternative-id":["S105488071630237X"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2017.04.002","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G)","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}